List of Zealand Pharma A/S patents

Patents where

Current Assignee

Name

Zealand Pharma A/S

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11278667 Time delay mechanism for a hydraulic drug delivery device	Patent 11278667 was granted and assigned to Zealand Pharma A/S on March, 2022 by the United States Patent and Trademark Office.	Valeritas	Zealand Pharma A/S	United States Patent and Trademark Office	11278667	March 22, 2022
‌ US Patent 7563770 Glucagon-like-peptide-2 (GLP-2) analogues	Patent 7563770 was granted and assigned to Zealand Pharma A/S on July, 2009 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	7563770	July 21, 2009
‌ US Patent 8642727 Selective glucagon-like-peptide-2 (GLP-2) analogues	Patent 8642727 was granted and assigned to Zealand Pharma A/S on February, 2014 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	8642727	February 4, 2014
‌ US Patent 7544657 Stabilized Exendin-4 compounds	Patent 7544657 was granted and assigned to Zealand Pharma A/S on June, 2009 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	7544657	June 9, 2009
‌ US Patent 11395847 Acylated GLP-1/GLP-2 dual agonists		Zealand Pharma A/S	Zealand Pharma A/S	United States Patent and Trademark Office	11395847	July 26, 2022
‌ US Patent 10100097 GIP-GLP-1 dual agonist compounds and methods	Patent 10100097 was granted and assigned to Zealand Pharma A/S on October, 2018 by the United States Patent and Trademark Office.	Zealand Pharma A/S	Zealand Pharma A/S	United States Patent and Trademark Office	10100097	October 16, 2018
‌ US Patent 8680049 Glucagon analogues	Patent 8680049 was granted and assigned to Zealand Pharma A/S on March, 2014 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	8680049	March 25, 2014
‌ US Patent 7994122 Glucagon analogues	Patent 7994122 was granted and assigned to Zealand Pharma A/S on August, 2011 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	7994122	August 9, 2011
‌ US Patent 10004786 Acylated glucagon analogues	Patent 10004786 was granted and assigned to Zealand Pharma A/S on June, 2018 by the United States Patent and Trademark Office.	Zealand Pharma A/S	Zealand Pharma A/S	United States Patent and Trademark Office	10004786	June 26, 2018
‌ US Patent 10071140 Amylin analogues	Patent 10071140 was granted and assigned to Zealand Pharma A/S on September, 2018 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	10071140	September 11, 2018
‌ US Patent 9453064 Glucagon-like-peptide-2 (GLP-2) analogues	Patent 9453064 was granted and assigned to Zealand Pharma A/S on September, 2016 by the United States Patent and Trademark Office.	Zealand Pharma A/S	Zealand Pharma A/S	United States Patent and Trademark Office	9453064	September 27, 2016
‌ US Patent 11274136 Acylated glucagon analogue	Patent 11274136 was granted and assigned to Zealand Pharma A/S on March, 2022 by the United States Patent and Trademark Office.	Zealand Pharma A/S	Zealand Pharma A/S	United States Patent and Trademark Office	11274136	March 15, 2022
‌ US Patent 8685919 Glucagon analogues	Patent 8685919 was granted and assigned to Zealand Pharma A/S on April, 2014 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	8685919	April 1, 2014
‌ US Patent 9649362 Peptide conjugates of GLP-1 receptor agonists and gastrin and their use	Patent 9649362 was granted and assigned to Zealand Pharma A/S on May, 2017 by the United States Patent and Trademark Office.	Zealand Pharma A/S	Zealand Pharma A/S	United States Patent and Trademark Office	9649362	May 16, 2017
‌ US Patent 9969787 Glucagon-like-peptide-2 (GLP-2) analogues	Patent 9969787 was granted and assigned to Zealand Pharma A/S on May, 2018 by the United States Patent and Trademark Office.	Zealand Pharma A/S	Zealand Pharma A/S	United States Patent and Trademark Office	9969787	May 15, 2018
‌ US Patent 9988429 Glucagon analogues	Patent 9988429 was granted and assigned to Zealand Pharma A/S on June, 2018 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	9988429	June 5, 2018
‌ US Patent 7550425 Diuretic peptide conjugates	Patent 7550425 was granted and assigned to Zealand Pharma A/S on June, 2009 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	7550425	June 23, 2009
‌ US Patent 9169310 Glucagon analogues	Patent 9169310 was granted and assigned to Zealand Pharma A/S on October, 2015 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	9169310	October 27, 2015
‌ US Patent 8642541 Glucagon analogues	Patent 8642541 was granted and assigned to Zealand Pharma A/S on February, 2014 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	8642541	February 4, 2014
‌ US Patent 8642540 Glucagon analogues	Patent 8642540 was granted and assigned to Zealand Pharma A/S on February, 2014 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	8642540	February 4, 2014
‌ US Patent 11382956 Amylin analogues	Patent 11382956 was granted and assigned to Zealand Pharma A/S on July, 2022 by the United States Patent and Trademark Office.	Zealand Pharma A/S	Zealand Pharma A/S	United States Patent and Trademark Office	11382956	July 12, 2022
‌ US Patent 9403894 Glucagon analogues	Patent 9403894 was granted and assigned to Zealand Pharma A/S on August, 2016 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	9403894	August 2, 2016
‌ US Patent 9975939 Glucagon analogues	Patent 9975939 was granted and assigned to Zealand Pharma A/S on May, 2018 by the United States Patent and Trademark Office.	Zealand Pharma A/S	Zealand Pharma A/S	United States Patent and Trademark Office	9975939	May 22, 2018
‌ US Patent 9180169 Glucagon analogues	Patent 9180169 was granted and assigned to Zealand Pharma A/S on November, 2015 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	9180169	November 10, 2015
‌ US Patent 9896495 Acylated glucagon analogues	Patent 9896495 was granted and assigned to Zealand Pharma A/S on February, 2018 by the United States Patent and Trademark Office.		Zealand Pharma A/S	United States Patent and Trademark Office	9896495	February 20, 2018

Results per page:

78 results

0 selected

78 results

0 selected